BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Telormedix 

Via della Posta 10

Bioggio    CH-6934  Switzerland
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder 5/16/2014 7:25:06 AM
Telormedix Raises $6.6 Million In Series B Financing Round 12/2/2013 10:40:38 AM
Molecular Profiles Selected to Develop Topical & Oral Psoriasis Products for Telormedix 9/23/2013 9:47:26 AM
Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis 8/7/2013 9:17:14 AM
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment 6/4/2012 10:26:45 AM
Telormedix and SUPSI Receive Funding from CTI/KTI for Research Collaboration on Molecular Modeling of Drug-Target Interactions 3/6/2012 10:01:39 AM
Telormedix Elected Member of TIMER Collaborative Research Program 1/31/2012 9:00:10 AM
Telormedix Secures Further Funding With $7.5 Million CHF 1/10/2012 8:20:44 AM
Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment 10/31/2011 9:13:42 AM
Telormedix Receives EU Funding to Coordinate the Development of Innovative Liposomes for Adjuvant and Vaccine Delivery 9/6/2011 10:44:12 AM
12